Recap: Tandem Diabetes Care Q1 Earnings

Tandem Diabetes Care TNDM reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Tandem Diabetes Care missed estimated earnings by 228.57%, reporting an EPS of $-0.23 versus an estimate of $-0.07.

Revenue was up $34.87 million from the same period last year.

Last quarter the company missed on EPS by $0.05 which was followed by a 1.84% drop in the share price the next day.

Here's a look at Tandem Diabetes Care's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	0.21	0.06	-0.08	-0.16
EPS Actual	0.16	0.09	0.06	-0.08
Revenue Estimate	199.12M	171.41M	143.63M	121.96M
Revenue Actual	210.00M	179.63M	172.14M	141.04M

To track all earnings releases for Tandem Diabetes Care visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar